NCT07201233View on ClinicalTrials.gov

Clinical Study on the Safety and Efficacy of Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression .

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

December 31, 2027

Conditions
Bone Marrow Suppression
Interventions
BIOLOGICAL

Umbilical cord blood

Umbilical cord blood transfusion should be performed 24 hours to 2 weeks after chemotherapy. One to multiple units of cord blood can be applied, and the minimum interval between two cord blood transfusions should be 2 weeks.

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

lead

Shandong Qilu Stem Cells Engineering Co., Ltd.

INDUSTRY

NCT07201233 - Clinical Study on the Safety and Efficacy of Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression . | Biotech Hunter | Biotech Hunter